Boireau A, Chambry J, Dubedat P, Farges G, Carruette A M, Zundel J L, Blanchard J C
Eur J Pharmacol. 1986 Aug 22;128(1-2):93-8. doi: 10.1016/0014-2999(86)90562-5.
The effects of chlorpromazine, pipotiazine, haloperidol, domperidone, sulpiride and SCH 23390 on the potassium-evoked release of [3H]acetylcholine [( 3H]ACh) were studied in rat striatal slices. All 5 dopamine (DA) antagonists with D-2 blockade efficacy induced an increase of [3H]ACh release whereas the specific D-1 antagonist SCH 23390 was devoid of significant effects. The maximal effect (about 100% increase) was obtained with haloperidol, pipotiazine and sulpiride but not with domperidone and chlorpromazine. Interestingly, sulpiride was found to exert an unexpected marked potency. The comparison of the activities of the 6 compounds on evoked ACh release to their affinities for D-2 receptors [( 3H]N-propylnorapomorphine binding sites) indicates that the pharmacological profile of the dopamine receptor implicated in the regulation of ACh release cannot be superimposed on that of the classical D-2 receptor. Participation of DA presynaptic receptors could however explain the differences in efficacy observed with the compounds studied.
在大鼠纹状体切片中研究了氯丙嗪、哌泊噻嗪、氟哌啶醇、多潘立酮、舒必利和SCH 23390对钾离子诱发的[3H]乙酰胆碱([3H]ACh)释放的影响。所有5种具有D-2受体阻断作用的多巴胺(DA)拮抗剂均能诱导[3H]ACh释放增加,而特异性D-1拮抗剂SCH 23390则无显著作用。氟哌啶醇、哌泊噻嗪和舒必利可产生最大效应(约增加100%),但多潘立酮和氯丙嗪则不然。有趣的是,发现舒必利具有意想不到的显著效力。将这6种化合物对诱发ACh释放的活性与其对D-2受体([3H]N-丙基去甲阿朴吗啡结合位点)的亲和力进行比较,结果表明,参与调节ACh释放的多巴胺受体的药理学特征不能与经典D-2受体的特征相叠加。然而,DA突触前受体的参与可以解释所研究化合物在效力上的差异。